Michael D. Hooven, Director at AtriCure, Inc. (ATRC), sold 28,866 shares at $20.00 ($577K) on 2014-12-31, disclosed to the SEC on 2015-01-02.
Scheduled sale ($577k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ATRC | SELL | 2015-04-01 | $1.5M | — | Filing → |
| ATRC | BUY | 2012-09-17 | $8K | — | Filing → |
| ATRC | BUY | 2012-09-14 | $8K | — | Filing → |